1. AB0197 Evaluation of Serum IL-10 and IP-10 Levels Is Useful as Prognostic Biomarkers for Selection of IL-6R Antibody (TCZ) Prior To Tumor Necrosis Factor (TNF) Inhibitor in Rheumatoid Arthritis Treatment. (15th July 2016) Authors: Kameda, T.; Dobashi, H.; Inoo, M.; Onishi, I.; Kurata, N.; Izumikawa, M.; Takeuchi, Y.; Nakashima, S.; Shimada, H.; Ozaki, H.; Wakiya, R.; Kadowaki, N. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0294 Lymphocyte Recovery after Methotrexate Discontinuation Relate To Spontaneous Regression of Mtx-Lpd in Ra Patients. (15th July 2016) Authors: Kameda, T.; Dobashi, H.; Inoo, M.; Onishi, I.; Kurata, N.; Izumikawa, M.; Nakashima, S.; Shimada, H.; Ozaki, H.; Wakiya, R.; Kadowaki, N. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0056 Serum IL-10 and IP-10 Levels is an Important Predictor of Response to Tocilizumab in Bio-Naïve RA Patients. (9th June 2015) Authors: Kameda, T.; Dobashi, H.; Inoo, M.; Onishi, I.; Kurata, N.; Susaki, K.; Wakiya, R.; Ozaki, H.; Nakashima, S.; Shimada, H.; Takeuchi, Y.; Izumikawa, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0065 CLINICAL FEATURES OF METHOTREXATE ASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN RHEUMATOID ARTHRITIS PATIENTS AND INFLUENCE OF CD8 POSITIVE LYMPHOCYTE INFILTRATION. (2nd June 2020) Authors: Kameda, T.; Nakashima, S.; Inoo, M.; Onishi, I.; Kurata, N.; Shimada, H.; Mahmoud Fahmy Mansour, M.; Wakiya, R.; Kato, M.; Ushio, Y.; Sugihara, K.; Miyagi, T.; Dobashi, H. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0207 A phase I/II clinical trial of intra-articular administration of ARG098, an anti-FAS IGM monoclonal antibody, in knee joint synovitis of japanese patients with rheumatoid arthritis. (23rd January 2014) Authors: Matsubara, T.; Okuda, K.; Chiba, J.; Takayama, A.; Inoue, H.; Sakurai, T.; Wakabayashi, H.; Kaneko, A.; Sugimoto, K.; Yamazaki, H.; Takanashi, T.; Takasaki, Y.; Tamura, N.; Ogasawara, M.; Inoo, M.; Onishi, I.; Kawai, S.; Nohara, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0111 Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective, randomised, controlled study (THE SECOND YEAR OF THE SURPRISE STUDY). (12th June 2018) Authors: Kaneko, Y.; Kato, M.; Tanaka, Y.; Inoo, M.; Kobayashi-Haraoka, H.; Amano, K.; Miyata, M.; Murakawa, Y.; Yasuoka, H.; Hirata, S.; Tanaka, E.; Miyasaka, N.; Yamanaka, H.; Yamamoto, K.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0124 Higher Methotrexate Dose May Increase the Frequency of Lymphoproliferative Disorders in Rheumatoid Arthritis Patients. (10th June 2014) Authors: Dobashi, H.; Kameda, T.; Inoo, M.; Onihsi, I.; Kurata, N.; Mitsunaka, H.; Susaki, K.; Izumikawa, M.; Nakashima, S.; Shimada, H.; Takeuchi, Y.; Ozaki, H.; Matsunaga, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗